Dr Reddys Laboratories (RDY) EBT Margin (2012 - 2026)

Dr Reddys Laboratories' EBT Margin history runs 15 years deep, the most recent figure standing at 2.26% for Q1 2026.

• In Q1 2026, EBT Margin fell 2132.0% year-over-year to 2.26%; the TTM figure through Mar 2026 stood at 16.53% (down 595.0% YoY), while the FY2026 annual figure was 16.31%, down 730.0% from the prior year.
• EBT Margin was 2.26% for Q1 2026 at Dr Reddys Laboratories, down from 17.68% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 29.6% in Q4 2023 to a low of 0.0% in Q3 2022.
• Historically, EBT Margin has averaged 21.35% across 5 years, with a median of 23.0% in 2024.
• The sharpest annual moves came in 2023 and 2026: EBT Margin surged 2781 bps in 2023, then slumped 2132 bps in 2026.
• A 5-year view of EBT Margin shows it stood at 21.12% in 2022, then surged by 40 bps to 29.6% in 2023, then dropped by 24 bps to 22.42% in 2024, then declined by 21 bps to 17.68% in 2025, then plunged by 87 bps to 2.26% in 2026.
• The last three EBT Margin figures came in at 2.26% (Q1 2026), 17.68% (Q4 2025), and 20.1% (Q2 2025), per Business Quant data.